Some patients with stage 3 non-small cell lung cancer saw benefits from Opdivo plus chemotherapy followed by surgery then Opdivo, researchers found. Patients with stage 3 N2 and stage 3 non-N2 ...
The 12-month survival rates in patients with non-clear cell renal cell carcinoma showed improvements after treatment with Yervoy plus Opdivo. A treatment combination with Yervoy (ipilimumab) plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback